There’s an urgent demand for new antimicrobial compounds that are effective against constantly emerging drug-resistant bacteria. Two robotic chemical-synthesizing machines, named Symphony X and Overture, have joined the search. Their specialty is creating custom nanoscale structures that mimic nature’s proven designs. They’re also fast, able to assemble dozens of compounds at a time.

Meet Doug Frantz. The Max and Minnie Tomerlin Voelcker Distinguished Professor in Chemistry was selected by the pharmaceutical company Eli Lilly & Co. to receive its Outstanding Open Innovation Drug Discovery Collaborator Award.

Janssen Pharmaceutical gift broadens strategic collaboration with School of Engineering.

For decades, scientists have known that ET-743, a compound extracted from a marine invertebrate called a mangrove tunicate, can kill cancer cells. The drug has been approved for use in patients in Europe and is in clinical trials in the U.S.

Researchers call for a fast and flexible regulatory response to the synthesis of morphine in genetically engineered yeast strains.

University of Adelaide researchers have discovered a target for the development of completely new antibiotics against disease-causing bacteria.

Doping is damaging the image of sport without benefitting athletes’ results, according to University of Adelaide research.

Salk Institute findings on premature aging syndrome could lead to way of slowing or reversing aging process.

Antibodies are specific molecules that can lock onto a particular cellular structure to start, stop or otherwise temper a biological process. Because they are so specific, antibodies are at the forefront of drug discovery. So drug companies want a faster route to step one: identifying which of the millions of possible antibodies will work against molecules that cause disease.

Syrup extract found to make antibiotics more effective against bacteria

Join Lab Manager’s panel of technical experts as they discuss some of the latest technology trends in the exciting and rapidly-changing drug discovery field

Big data might bring more benefits to drug discovery than to any other field. For one thing, discovering a new drug turns out to be incredibly difficult. On average, a pharmaceutical company tries about 10,000 drug candidates for every one that ends up on the market. Plus, the process of discovering and developing a new drug costs hundreds of millions of dollars and takes more than a decade—some say more for both measurements.